291 related articles for article (PubMed ID: 29605476)
1. ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer.
Nestle U; De Ruysscher D; Ricardi U; Geets X; Belderbos J; Pöttgen C; Dziadiuszko R; Peeters S; Lievens Y; Hurkmans C; Slotman B; Ramella S; Faivre-Finn C; McDonald F; Manapov F; Putora PM; LePéchoux C; Van Houtte P
Radiother Oncol; 2018 Apr; 127(1):1-5. PubMed ID: 29605476
[TBL] [Abstract][Full Text] [Related]
2. ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer.
Le Pechoux C; Faivre-Finn C; Ramella S; McDonald F; Manapov F; Putora PM; Slotman B; De Ruysscher D; Ricardi U; Geets X; Belderbos J; Pöttgen C; Dziadiuszko R; Peeters S; Lievens Y; Hurkmans C; Van Houtte P; Nestle U
Radiother Oncol; 2020 Nov; 152():89-95. PubMed ID: 32673777
[TBL] [Abstract][Full Text] [Related]
3. ESTRO ACROP guidelines for target volume definition in pancreatic cancer.
Brunner TB; Haustermans K; Huguet F; Morganti AG; Mukherjee S; Belka C; Krempien R; Hawkins MA; Valentini V; Roeder F
Radiother Oncol; 2021 Jan; 154():60-69. PubMed ID: 32861703
[TBL] [Abstract][Full Text] [Related]
4. Difference in target definition using three different methods to include respiratory motion in radiotherapy of lung cancer.
Sloth Møller D; Knap MM; Nyeng TB; Khalil AA; Holt MI; Kandi M; Hoffmann L
Acta Oncol; 2017 Nov; 56(11):1604-1609. PubMed ID: 28885090
[TBL] [Abstract][Full Text] [Related]
5. The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.
Vanuytsel LJ; Vansteenkiste JF; Stroobants SG; De Leyn PR; De Wever W; Verbeken EK; Gatti GG; Huyskens DP; Kutcher GJ
Radiother Oncol; 2000 Jun; 55(3):317-24. PubMed ID: 10869746
[TBL] [Abstract][Full Text] [Related]
6. Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer.
Apolle R; Appold S; Bijl HP; Blanchard P; Bussink J; Faivre-Finn C; Khalifa J; Laprie A; Lievens Y; Madani I; Ruffier A; de Ruysscher D; van Elmpt W; Troost EGC
Acta Oncol; 2019 Oct; 58(10):1378-1385. PubMed ID: 31271079
[No Abstract] [Full Text] [Related]
7. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
[TBL] [Abstract][Full Text] [Related]
8. Variation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: Recommendations for prescribing and recording according to the ACROP guideline and ICRU report 91.
de Jong EEC; Guckenberger M; Andratschke N; Dieckmann K; Hoogeman MS; Milder M; Møller DS; Nyeng TB; Tanadini-Lang S; Lartigau E; Lacornerie T; Senan S; Verbakel W; Verellen D; De Kerf G; Hurkmans C
Radiother Oncol; 2020 Jan; 142():217-223. PubMed ID: 31767472
[TBL] [Abstract][Full Text] [Related]
9. Deep inspiration breath hold in locally advanced lung cancer radiotherapy: validation of intrafractional geometric uncertainties in the INHALE trial.
Josipovic M; Aznar MC; Thomsen JB; Scherman J; Damkjaer SM; Nygård L; Specht L; Pøhl M; Persson GF
Br J Radiol; 2019 Dec; 92(1104):20190569. PubMed ID: 31544478
[TBL] [Abstract][Full Text] [Related]
10. [Target volume margins for lung cancer: internal target volume/clinical target volume].
Jouin A; Pourel N
Cancer Radiother; 2013 Oct; 17(5-6):428-33. PubMed ID: 23988437
[TBL] [Abstract][Full Text] [Related]
11. The delineation of target volumes for radiotherapy of lung cancer patients.
Vorwerk H; Beckmann G; Bremer M; Degen M; Dietl B; Fietkau R; Gsänger T; Hermann RM; Alfred Herrmann MK; Höller U; van Kampen M; Körber W; Maier B; Martin T; Metz M; Richter R; Siekmeyer B; Steder M; Wagner D; Hess CF; Weiss E; Christiansen H
Radiother Oncol; 2009 Jun; 91(3):455-60. PubMed ID: 19339069
[TBL] [Abstract][Full Text] [Related]
12. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
[TBL] [Abstract][Full Text] [Related]
13. A teaching intervention in a contouring dummy run improved target volume delineation in locally advanced non-small cell lung cancer: Reducing the interobserver variability in multicentre clinical studies.
Schimek-Jasch T; Troost EG; Rücker G; Prokic V; Avlar M; Duncker-Rohr V; Mix M; Doll C; Grosu AL; Nestle U
Strahlenther Onkol; 2015 Jun; 191(6):525-33. PubMed ID: 25665799
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
[TBL] [Abstract][Full Text] [Related]
15. A Prospective Study Comparing Dosimetry between Computed Tomography (CT) based Radiation Planning and Positron Emission Computed Tomography (PET-CT) based Radiation Planning in Treatment of Non-Metastatic Non Small Cell Lung Carcinoma.
Mandal B; Basu A; Manna A; Mondal J; Ghosh D; Chakraborty I; Biswas J; Chakraborty A
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2543-2550. PubMed ID: 37505789
[TBL] [Abstract][Full Text] [Related]
16. ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer.
Salembier C; Villeirs G; De Bari B; Hoskin P; Pieters BR; Van Vulpen M; Khoo V; Henry A; Bossi A; De Meerleer G; Fonteyne V
Radiother Oncol; 2018 Apr; 127(1):49-61. PubMed ID: 29496279
[TBL] [Abstract][Full Text] [Related]
17. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET definition of gross tumor volume for radiotherapy of lung cancer: is the tumor uptake value-based approach appropriate for lymph node delineation?
Rodríguez N; Sanz X; Trampal C; Foro P; Reig A; Lacruz M; Membrive I; Lozano J; Quera J; Algara M
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):659-66. PubMed ID: 20133071
[TBL] [Abstract][Full Text] [Related]
19. Use of PET/CT for staging and radiation therapy planning in patients with non-small cell lung cancer.
Mac Manus MP
Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):510-20. PubMed ID: 20927018
[TBL] [Abstract][Full Text] [Related]
20. Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation.
Steenbakkers RJ; Duppen JC; Fitton I; Deurloo KE; Zijp L; Uitterhoeve AL; Rodrigus PT; Kramer GW; Bussink J; De Jaeger K; Belderbos JS; Hart AA; Nowak PJ; van Herk M; Rasch CR
Radiother Oncol; 2005 Nov; 77(2):182-90. PubMed ID: 16256231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
